Ruth Langley

scientistFemale0.0Global Dominance: 0.00%

Prof. Ruth Langley is a prominent researcher at University College London, currently leading the Add-Aspirin trial, which investigates the potential of aspirin in preventing the recurrence of early-stage cancers.

Power0

Reach0

Collect

Not in the pool (under ¢1).

Recent news mentions

Prof Ruth Langley, from the MRC Clinical Trials Unit at University College London, is leading the Add-Aspirin trial to see if aspirin can stop early stage cancers from coming back.

Scientists crack how painkiller might stop cancers from spreading

BBC·

United Kingdom· 2025-03-05

8.0

Also mentioned

Rahul Roychoudhuri

Mangesh Thorat

Jie Yang

Prof Ruth Langley at University College London is leading a trial called Add-Aspirin to explore whether aspirin can prevent early-stage cancers from returning.

This common painkiller can stop cancer from spreading; breakthrough study finds

The Times of India·

India· 2025-03-05

8.0

Also mentioned

Rahul Roychoudhuri